JPWO2023107894A5 - - Google Patents
Info
- Publication number
- JPWO2023107894A5 JPWO2023107894A5 JP2024533880A JP2024533880A JPWO2023107894A5 JP WO2023107894 A5 JPWO2023107894 A5 JP WO2023107894A5 JP 2024533880 A JP2024533880 A JP 2024533880A JP 2024533880 A JP2024533880 A JP 2024533880A JP WO2023107894 A5 JPWO2023107894 A5 JP WO2023107894A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- dose
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163286345P | 2021-12-06 | 2021-12-06 | |
| US63/286,345 | 2021-12-06 | ||
| US202263317573P | 2022-03-08 | 2022-03-08 | |
| US63/317,573 | 2022-03-08 | ||
| US202263370056P | 2022-08-01 | 2022-08-01 | |
| US63/370,056 | 2022-08-01 | ||
| PCT/US2022/080928 WO2023107894A1 (en) | 2021-12-06 | 2022-12-05 | Combination therapy comprising a pkc inhibitor and a c-met inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542831A JP2024542831A (ja) | 2024-11-15 |
| JPWO2023107894A5 true JPWO2023107894A5 (https=) | 2025-12-15 |
| JP2024542831A5 JP2024542831A5 (https=) | 2025-12-15 |
Family
ID=86731264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533880A Pending JP2024542831A (ja) | 2021-12-06 | 2022-12-05 | Ｐｋｃ阻害剤及びｃ－ｍｅｔ阻害剤を含む併用療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240335440A1 (https=) |
| EP (1) | EP4444303A4 (https=) |
| JP (1) | JP2024542831A (https=) |
| AU (1) | AU2022407330A1 (https=) |
| CA (1) | CA3239676A1 (https=) |
| IL (1) | IL313361A (https=) |
| MX (1) | MX2024006948A (https=) |
| WO (1) | WO2023107894A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014174478A1 (en) * | 2013-04-26 | 2014-10-30 | Novartis Ag | Pharmaceutical combinations of a pkc inhibitor and a c-met receptor tyrosine kinase inhibitor |
| CA2955676A1 (en) * | 2014-08-25 | 2016-03-03 | Pfizer Inc. | Combination of a pd-1 antagonist and an alk inhibitor for treating cancer |
| US11413284B2 (en) * | 2017-09-12 | 2022-08-16 | Novartis Ag | Protein kinase C inhibitors for treatment of uveal melanoma |
| AU2020386903A1 (en) * | 2019-11-18 | 2022-06-09 | Ideaya Biosciences, Inc. | Dosing regimens for a protein kinase C inhibitor |
| JP2023541011A (ja) * | 2020-09-08 | 2023-09-27 | イデアヤ、バイオサイエンシズ、インコーポレイテッド | 医薬組み合わせおよび腫瘍治療 |
-
2022
- 2022-12-05 JP JP2024533880A patent/JP2024542831A/ja active Pending
- 2022-12-05 MX MX2024006948A patent/MX2024006948A/es unknown
- 2022-12-05 WO PCT/US2022/080928 patent/WO2023107894A1/en not_active Ceased
- 2022-12-05 US US18/715,927 patent/US20240335440A1/en active Pending
- 2022-12-05 EP EP22905269.1A patent/EP4444303A4/en active Pending
- 2022-12-05 IL IL313361A patent/IL313361A/en unknown
- 2022-12-05 CA CA3239676A patent/CA3239676A1/en active Pending
- 2022-12-05 AU AU2022407330A patent/AU2022407330A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP2002512194A (ja) | 医原性および年齢関連性高血圧症の治療方法、およびこれに有用な医薬組成物 | |
| JPH0647532B2 (ja) | 歯槽骨吸収の治療 | |
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2021120379A5 (https=) | ||
| JP2006504795A5 (https=) | ||
| EP0533281B1 (en) | The use of ranitidine bismuth citrate and in combination with claritromycin or claritromycin and tetracyclin in the manufacture of a medicament for treating gastrointestinal disorders | |
| JP2024178420A5 (https=) | ||
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| US20070225262A2 (en) | Method for the treatment of acne | |
| KR20010015918A (ko) | 안면홍조를 감소시키기 위한 플루옥세틴 히드로클로라이드 | |
| JPWO2019241442A5 (https=) | ||
| CA2442410A1 (en) | Duloxetine for treatment of hot flashes | |
| KR20120089623A (ko) | 정맥내 투여용 이부프로펜을 이용한 환자의 치료 | |
| JPWO2023107894A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| JP2021091608A5 (https=) | ||
| JP2021511352A5 (https=) | ||
| US20040152733A1 (en) | Duloxetine for treatment of hot flashes | |
| JPWO2022232494A5 (https=) | ||
| JP2021169472A5 (https=) | ||
| JPWO2021142030A5 (https=) | ||
| JPWO2023018904A5 (https=) | ||
| JP2012025734A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
| CN1762351A (zh) | 用于治疗口腔炎症的替硝唑口腔贴片 |